Adverse events per woman · patients with final oocyte maturation triggering in IVF and ICSI cycles
1 finding from 1 review
Moderate or severe OHSS · patients with final oocyte maturation triggering in IVF and ICSI cycles
RhCG showed no clear difference in OHSS per woman ‐ moderate to severe OHSS compared with uhCG (low certainty).
1 finding from 1 review
Clinical pregnancy rate · patients with final oocyte maturation triggering in IVF and ICSI cycles
RhCG showed no clear difference in clinical pregnancy rate per woman compared with uhCG (moderate certainty).
1 finding from 1 review
Miscarriage · patients with final oocyte maturation triggering in IVF and ICSI cycles
RhCG showed no clear difference in miscarriage rate per woman compared with uhCG (low certainty).
1 finding from 1 review
Adverse events per woman · patients with final oocyte maturation triggering in IVF and ICSI cycles
RhCG probably leads to lower adverse events per woman compared with uhCG (moderate certainty).
1 finding from 1 review
Ongoing pregnancy / live birth rate per woman · patients with final oocyte maturation triggering in IVF and ICSI cycles
It is very uncertain whether rhLH changes ongoing pregnancy/live birth rate per woman compared with uhCG (very low certainty).
1 finding from 1 review
Incidence of moderate OHSS · patients with final oocyte maturation triggering in IVF and ICSI cycles
It is very uncertain whether rhLH changes OHSS per woman ‐ Moderate OHSS compared with uhCG (very low certainty).
1 finding from 1 review
Clinical pregnancy rate · patients with final oocyte maturation triggering in IVF and ICSI cycles
It is very uncertain whether rhLH changes clinical pregnancy rate per woman compared with uhCG (very low certainty).
1 finding from 1 review
Miscarriage · patients with final oocyte maturation triggering in IVF and ICSI cycles
It is very uncertain whether rhLH changes miscarriage rate per woman compared with uhCG (very low certainty).
1 finding from 1 review
Control of bleeding (cure or improvement to acceptable level) At 2 years · women with heavy menstrual bleeding
Surgery probably leads to higher control of bleeding (cure or improvement to acceptable level) At 4… compared with oral medication (moderate certainty).
3 findings from 1 review
RR 2.66 [1.94, 3.64]
1 study · 186 participants
Moderate
RR 1.29 [1.06, 1.57]
1 study · 173 participants
Low
RR 1.14 [0.97, 1.34]
1 study · 140 participants
Very low
Satisfaction rate: surgery versus LNG‐IUS Endometrial ablation versus LNG‐IUS At 2 years · women with heavy menstrual bleeding
Surgery showed no clear difference in satisfaction rate: surgery versus LNG‐IUS Endometrial ablation… compared with LNG‐IUS (low certainty).
1 finding from 1 review
Proportion of women with adverse events Endometrial ablation versus LNG‐IUS. At one year · women with heavy menstrual bleeding
Surgery probably leads to lower proportion of women with adverse events Endometrial ablation versus… compared with LNG‐IUS (moderate certainty).
1 finding from 1 review
Overall satisfaction with treatment At 2 years · women with heavy menstrual bleeding
Surgery probably leads to higher overall satisfaction with treatment At 2 years compared with oral medication (moderate certainty).
1 finding from 1 review
Overall satisfaction with treatment At 5 years · women with heavy menstrual bleeding
It is very uncertain whether surgery changes overall satisfaction with treatment At 5 years compared with oral medication (very low certainty).
1 finding from 1 review
Adverse events at 4 months · women with heavy menstrual bleeding
Surgery probably leads to lower adverse events at 4 months compared with oral medication (moderate certainty).
1 finding from 1 review
Objective control of bleeding: menstrual loss under 80 ml per cycle LNG‐IUS versus hysterectomy At 1 year · women with heavy menstrual bleeding
Surgery probably leads to higher objective control of bleeding: menstrual loss under 80 ml per cycle… compared with LNG‐IUS (moderate certainty).
1 finding from 1 review
Subjective control of bleeding: PBAC no more than 75 per cycle Endometrial resection or ablation versus LNG‐IUS At 1 year · women with heavy menstrual bleeding
Surgery may leads to higher subjective control of bleeding: PBAC no more than 75 per cycle… compared with LNG‐IUS (low certainty).
1 finding from 1 review
Satisfaction rate: surgery versus LNG‐IUS Endometrial ablation versus LNG‐IUS At 1 year · women with heavy menstrual bleeding
Surgery showed no clear difference in satisfaction rate: surgery versus LNG‐IUS Endometrial ablation… compared with LNG‐IUS (low certainty).
1 finding from 1 review
Awareness of prolapse · women with anterior compartment pelvic organ prolapse
Anterior prolapse repair: native tissue showed no clear difference in awareness of prolapse (1‐2 years) compared with biological graft (low certainty).
1 finding from 1 review
De novo stress urinary incontinence review 1 to 3 years · women with anterior compartment pelvic organ prolapse
Anterior prolapse repair: native tissue showed no clear difference in stress urinary incontinence (de novo) (1‐3 years) compared with polypropylene mesh (low certainty).
1 finding from 1 review